Brief: Hemogenyx Pharma Signs LOI To Advance Commercialization Of HG-CT-1 CAR-T Therapy In Estonia
23/09/2025 07:41
Sept 23 (Reuters) - Hemogenyx Pharmaceuticals PLC HEMO.L: HEMOGENYX PHARMA PLC - HEMOGENYX SIGNS LETTER OF INTENT HEMOGENYX PHARMACEUTICALS PLC - SIGNS LOI WITH CELLIN TO ADVANCE COMMERCIALIZATION OF HG-CT-1 CAR-T THERAPY IN ESTONIA HEMOGENYX PHARMACEUTICALS PLC - RETAINS FULL OWNERSHIP OF HG-CT-1 IP & WILL BE ENTITLED TO REVENUES FROM COMMERCIALIZATION Source text: ID:nRSW2993Aa Further company coverage: HEMO.L ((Reuters.Briefs@thomsonreuters.com;))